{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:40:32Z","timestamp":1787611232824,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.051","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T04:42:25Z","timestamp":1317271345000},"page":"9081-9092","source":"Crossref","is-referenced-by-count":41,"title":["Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Kirsten","family":"Schneider-Ohrum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather K.","family":"Weirback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilhari R.","family":"DeAlmeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.09.051_bib0005","unstructured":"Lamb, R.A., Krug, R.M., Orthomyxoviridae: the viruses and their replication, in H.P.M. D.M. Knipe, D.E. Griffin, M.A. Malcolm, R.A. Lamb, B. Roizman (Eds.), Fields Virology, Lippincott Williams and Wilkins, Philadelphia, 2001, p. 435\u2013468."},{"issue":"10","key":"10.1016\/j.vaccine.2011.09.051_bib0010","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","article-title":"Mortality benefits of influenza vaccination in elderly people: an ongoing controversy","volume":"7","author":"Simonsen","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/515616","article-title":"Pandemic versus epidemic influenza mortality: a pattern of changing age distribution","volume":"178","author":"Simonsen","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.051_bib0020","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.ppat.0030040","article-title":"H5N1 viruses and vaccines","volume":"3","author":"Subbarao","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb01010.x","article-title":"Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections","volume":"159","author":"Doherty","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1997.tb01009.x","article-title":"Role of the B-cell response in recovery of mice from primary influenza virus infection","volume":"159","author":"Gerhard","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","article-title":"Structural basis of immune recognition of influenza virus hemagglutinin","volume":"8","author":"Wilson","year":"1990","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.051_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000221","article-title":"Age-related changes in immunity: implications for vaccination in the elderly","volume":"9","author":"Kovaiou","year":"2007","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.051_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.2007.02555.x","article-title":"Immunosenescence: emerging challenges for an ageing population","volume":"120","author":"Aw","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4933-4-9","article-title":"Challenges for vaccination in the elderly","volume":"4","author":"Aspinall","year":"2007","journal-title":"Immun Ageing"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.051_bib0055","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.051_bib0060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2010.04.004","article-title":"New adjuvants for human vaccines","volume":"22","author":"Mbow","year":"2010","journal-title":"Curr Opin Immunol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2011.09.051_bib0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","article-title":"The path to a successful vaccine adjuvant -- \u2018the long and winding road\u2019","volume":"14","author":"O\u2018Hagan","year":"2009","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.051_bib0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0075","doi-asserted-by":"crossref","first-page":"e1501","DOI":"10.1371\/journal.pone.0001501","article-title":"Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle","volume":"3","author":"Bright","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1465-9921-10-112","article-title":"Impaired immune responses in the lungs of aged mice following influenza infection","volume":"10","author":"Toapanta","year":"2009","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.051_bib0085","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.00005-06","article-title":"Emerging respiratory viruses: challenges and vaccine strategies","volume":"19","author":"Gillim-Ross","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"20","key":"10.1016\/j.vaccine.2011.09.051_bib0090","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1128\/JVI.76.20.10332-10337.2002","article-title":"Mice deficient in perforin: CD4+ T cells, or CD28-mediated signaling maintain the typical immunodominance hierarchies of CD8+ T-cell responses to influenza virus","volume":"76","author":"Chen","year":"2002","journal-title":"J Virol"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2011.09.051_bib0095","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","article-title":"The global impact of vaccines containing aluminium adjuvants","volume":"20","author":"Clements","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.051_bib0100","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/315323","article-title":"Correlates of immune protection induced by live: attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine","volume":"181","author":"Belshe","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.virol.2009.12.003","article-title":"Safety, immunogencity, and efficacy of a cold-adapted A\/Ann Arbor\/6\/60 (H2N2) vaccine in mice and ferrets","volume":"398","author":"Chen","year":"2010","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.051_bib0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/1745509X.4.6.603","article-title":"Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines","volume":"4","author":"McElhaney","year":"2008","journal-title":"Aging health"},{"issue":"21","key":"10.1016\/j.vaccine.2011.09.051_bib0115","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.272.21.1661","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial","volume":"272","author":"Govaert","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-3-540-92165-3_20","article-title":"Immunosenescence and influenza vaccine efficacy","volume":"333","author":"Sambhara","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.micinf.2009.09.007","article-title":"Interplay between influenza A virus and the innate immune signaling","volume":"12","author":"Ehrhardt","year":"2010","journal-title":"Microbes Infect"},{"issue":"18","key":"10.1016\/j.vaccine.2011.09.051_bib0130","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1128\/JVI.00530-07","article-title":"Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo","volume":"81","author":"Jewell","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0135","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.4049\/jimmunol.181.10.6747","article-title":"Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation","volume":"181","author":"Stout-Delgado","year":"2008","journal-title":"J Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2011.09.051_bib0140","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.vaccine.2011.05.001","article-title":"Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)","volume":"29","author":"Taylor","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.051_bib0145","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.0901022","article-title":"Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response","volume":"184","author":"Panda","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0167-5699(95)80064-6","article-title":"The immunology of exceptional individuals: the lesson of centenarians","volume":"16","author":"Franceschi","year":"1995","journal-title":"Immunol Today"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.051_bib0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2249.1992.tb07954.x","article-title":"Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population","volume":"90","author":"Paganelli","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ageing\/20.1.33","article-title":"Ageing and duodenal mucosal immunity","volume":"20","author":"Penn","year":"1991","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.051_bib0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1051\/vetres:2006010","article-title":"The IgA system: a comparison of structure and function in different species","volume":"37","author":"Snoeck","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2003.11.018","article-title":"The Fc receptor for IgA (FcalphaRI, CD89)","volume":"92","author":"Otten","year":"2004","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.051_bib0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.coi.2009.06.001","article-title":"Effects of aging on B cell function","volume":"21","author":"Frasca","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"51","key":"10.1016\/j.vaccine.2011.09.051_bib0180","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1016\/j.vaccine.2010.10.023","article-title":"Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans","volume":"28","author":"Frasca","year":"2010","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2011.09.051_bib0185","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1128\/JVI.00266-10","article-title":"Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus","volume":"84","author":"Miao","year":"2010","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.09.051_bib0190","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0047-6374(02)00010-6","article-title":"Age-associated decrease in virus-specific CD8+ T lymphocytes during primary influenza infection","volume":"123","author":"Po","year":"2002","journal-title":"Mech Ageing Dev"},{"issue":"14","key":"10.1016\/j.vaccine.2011.09.051_bib0195","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"N Engl J Med"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2011.09.051_bib0200","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0264-410X(02)00041-5","article-title":"A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community","volume":"20","author":"Vu","year":"2002","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2011.09.051_bib0205","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin","volume":"25","author":"Bright","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.09.051_bib0210","doi-asserted-by":"crossref","first-page":"e6032","DOI":"10.1371\/journal.pone.0006032","article-title":"A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets","volume":"4","author":"Ross","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2011.09.051_bib0215","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14712591003724662","article-title":"MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk","volume":"10","author":"Durando","year":"2010","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.vaccine.2011.09.051_bib0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.antiviral.2009.09.005","article-title":"Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge","volume":"84","author":"Wen","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0225","unstructured":"Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010. MMWR Morb Mortal Wkly Rep. 59(16): 485\u20136."},{"issue":"13","key":"10.1016\/j.vaccine.2011.09.051_bib0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.vaccine.2011.09.051_bib0235","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1128\/JVI.00596-10","article-title":"An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice","volume":"84","author":"Lau","year":"2010","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2011.09.051_bib0240","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0264-410X(00)00022-0","article-title":"A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice","volume":"18","author":"Katz","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0245","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.0105-2896.2005.00259.x","article-title":"The role of CD8+ T-cell replicative senescence in human aging","volume":"205","author":"Effros","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2011.09.051_bib0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.0105-2896.2005.00255.x","article-title":"The effect of age on the cognate function of CD4+ T cells","volume":"205","author":"Haynes","year":"2005","journal-title":"Immunol Rev"},{"issue":"23","key":"10.1016\/j.vaccine.2011.09.051_bib0255","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s00018-005-5290-1","article-title":"Generation of improved mucosal vaccines by induction of innate immunity","volume":"62","author":"Lavelle","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"10.1016\/j.vaccine.2011.09.051_bib0260","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J Virol"},{"issue":"12\u201313","key":"10.1016\/j.vaccine.2011.09.051_bib0265","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.micinf.2006.07.018","article-title":"Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection","volume":"8","author":"Asahi-Ozaki","year":"2006","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.051_bib0270","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Kawai","year":"2006","journal-title":"Cell Death Differ"},{"issue":"7","key":"10.1016\/j.vaccine.2011.09.051_bib0275","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","article-title":"TLR3: interferon induction by double-stranded RNA including poly(I:C)","volume":"60","author":"Matsumoto","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"issue":"7028","key":"10.1016\/j.vaccine.2011.09.051_bib0280","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2011.09.051_bib0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.smim.2009.05.010","article-title":"The role of CD40 and CD154\/CD40L in dendritic cells","volume":"21","author":"Ma","year":"2009","journal-title":"Semin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.051_bib0290","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cellimm.2004.07.001","article-title":"Impaired antigen-induced CD8+ T cell clonal expansion in aging is due to defects in antigen presenting cell function","volume":"229","author":"Plowden","year":"2004","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.2001.1799","article-title":"Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses","volume":"210","author":"Sambhara","year":"2001","journal-title":"Cell Immunol"},{"issue":"42","key":"10.1016\/j.vaccine.2011.09.051_bib0300","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1016\/j.vaccine.2008.07.084","article-title":"H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses","volume":"26","author":"Mahmood","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.051_bib0305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2010.07.008","article-title":"Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice","volume":"406","author":"Lau","year":"2010","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T20:54:24Z","timestamp":1543524864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":61,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11014575"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}